UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
August 21, 2000
--------------------------------
(Date of earliest event reported)
BioMeridian Corporation
(formerly Magellan Technology, Inc.)
------------------------------------
(Exact name of registrant as specified in its charter)
Utah 0-18271 87-0284979
---------------------------- --------------------- -------------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
12411 South 265 West, Suite F
Draper, Utah 84020
------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: (801) 501-7517
<PAGE>
Item 5. Other Events
On July 7, 2000, at the annual meeting of shareholders, the
shareholders of Magellan Technology, Inc. voted to change the corporation's name
from Magellan Technology, Inc. to BioMeridian Corporation (the "Company"). On
August 1, 2000, the Company filed Articles of Amendment to Articles of
Incorporation of Magellan Technology, Inc. with the Utah Division of
Corporations and Commercial Code reflecting the name change to BioMeridian
Corporation, a copy of which is attached hereto. Additionally, a press release
issued following the shareholders meeting regarding the name change is attached,
but not incorporated herein.
Effective as of August 16, 2000, Nasdaq assigned the symbol "BIDN" as
the new trading symbol (replacing "MGLN") for the Company's common stock. The
Company believes its common stock began trading under the symbol BIDN on or
about such date.
Item 7. Financial Statements and Exhibits
(c) Exhibits.
99.1 Articles of Amendment to Articles of Incorporation
of Magellan Technology, Inc.
99.2 Press Release issued by Magellan Technology, Inc.
on July 12, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this Current Report on Form 8-K to be signed on
its behalf by the undersigned thereunto duly authorized.
BioMeridian Corporation
By: /s/ William A. Fresh
------------------------
William A. Fresh, Chairman and CEO
Date: August 18, 2000
